HIMS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HIMS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Hims & Hers Health's annualized ROCE % for the quarter that ended in Dec. 2024 was 15.90%.
The historical data trend for Hims & Hers Health's ROCE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hims & Hers Health Annual Data | |||||||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||
ROCE % | Get a 7-Day Free Trial | -19.55 | -51.72 | -20.82 | -8.78 | 14.76 |
Hims & Hers Health Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
ROCE % | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-0.47 | 11.20 | 12.14 | 21.79 | 15.90 |
Hims & Hers Health's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:
ROCE % | = | EBIT | / | ( (Capital Employed | + | Capital Employed) | / count ) |
(A: Dec. 2024 ) | (A: Dec. 2023 ) | (A: Dec. 2024 ) | |||||
= | EBIT | / | ( ( (Total Assets - Total Current Liabilities) | + | (Total Assets - Total Current Liabilities) ) | / count ) | |
(A: Dec. 2024 ) | (A: Dec. 2023 ) | (A: Dec. 2024 ) | |||||
= | 61.903 | / | ( ( (441.186 - 88.468) | + | (707.539 - 221.367) ) | / 2 ) | |
= | 61.903 | / | ( (352.718 | + | 486.172) | / 2 ) | |
= | 61.903 | / | 419.445 | ||||
= | 14.76 % |
Hims & Hers Health's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:
ROCE % | = | EBIT (1) | / | ( (Capital Employed | + | Capital Employed) | / count ) |
(Q: Dec. 2024 ) | (Q: Sep. 2024 ) | (Q: Dec. 2024 ) | |||||
= | EBIT | / | ( ( (Total Assets - Total Current Liabilities) | + | (Total Assets - Total Current Liabilities) ) | / count ) | |
(Q: Dec. 2024 ) | (Q: Sep. 2024 ) | (Q: Dec. 2024 ) | |||||
= | 74.384 | / | ( ( (602.261 - 152.645) | + | (707.539 - 221.367) ) | / 2 ) | |
= | 74.384 | / | ( ( 449.616 | + | 486.172 ) | / 2 ) | |
= | 74.384 | / | 467.894 | ||||
= | 15.90 % |
(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hims & Hers Health (NYSE:HIMS) ROCE % Explanation
ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.
Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.
Thank you for viewing the detailed overview of Hims & Hers Health's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.
Melissa Baird | officer: Chief Operating Officer | 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123 |
Oluyemi Okupe | officer: Chief Financial Officer | 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123 |
Michael Chi | officer: Chief Marketing Officer | 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123 |
Soleil Boughton | officer: See Remarks | 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123 |
Andrew Dudum | director, 10 percent owner, officer: Chief Executive Officer | 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123 |
Irene Becklund | officer: Interim PFO/PAO | 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123 |
David B Wells | director | C/O NETFLIX, INC., 100 WINCHESTER CIRCLE, LOS GATOS CA 95130 |
Patrick Harrison Carroll | officer: Chief Medicall Officer | 2269 CHESTNUT STREET, # 523, SAN FRANCISCO CA 94123 |
Christiane Pendarvis | director | 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123 |
Lynne Chou O'keefe | director | 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123 |
Alex Bard | director | 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123 |
Jules A. Maltz | director | 3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025 |
Ivp Executive Fund Xvi, Llc | 10 percent owner | 3000 SAND HILL ROAD, BUILDING 2, SUITE 2, MENLO PARK CA 94025 |
Somesh Dash | 10 percent owner | 3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025 |
Jack Abraham | 10 percent owner | 1 LETTERMAN DRIVE, SUITE C3500, SAN FRANCISCO CA 94129 |
From GuruFocus
By Business Wire • 02-19-2025
By GuruFocus News • 02-05-2025
By GuruFocus News • 01-17-2025
By Khac Phu Nguyen • 12-19-2024
By GuruFocus News • 02-03-2025
By GuruFocus News • 01-04-2025
By GuruFocus News • 01-21-2025
By GuruFocus News • 01-10-2025
By Khac Phu Nguyen • 02-19-2025
By GuruFocus News • 02-19-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.